Invesco’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$2.34M Buy
2024
Q1
$1.66M Buy
2023
Q4
$1.29M Sell
2023
Q3
$699K Sell
2023
Q2
$1.03M Buy
2023
Q1
$778K Buy
2022
Q4
$967K Buy
2022
Q3
$643K Buy
2022
Q2
$558K Buy
2022
Q1
$610K Sell
2021
Q4
$575K Sell
2021
Q3
$10.5M Buy
2021
Q2
$317K Buy